EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions

Abu-Bakr Ahmed iD, Spencer Thatcher, Joshua Khorsandi iD, Zahra Ahmed, Michael Lee iD, Adam Jaouhari iD, Braydon Bond, Aftab Merchant iD

Journal of Clinical Medicine · 03.12.2025 · 14 (23) · 8583

DOI: 10.3390/jcm14238583 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.12.2025. Verfasst von Abu-Bakr Ahmed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kirk Kerkorian School of Medicine at the University of Nevada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic cutaneous wounds such as diabetic foot ulcers, venous leg ulcers, pressure injuries, and burns remain a global clinical burden. These wounds are often arrested in inflammatory or ischemic stages due to impaired angiogenesis and growth factor deficiencies. Biologic therapies, such as platelet-rich plasma (PRP) and recombinant growth factors, aim to restore these deficits and accelerate repair.

Methods

A narrative review of PubMed and Google Scholar (2015–2025) identified 64 English-language studies, including randomized controlled trials, meta-analyses, and translational investigations evaluating PRP and recombinant growth factors in wound healing.

Results

Randomized trials and meta-analyses show that adjunctive autologous PRP increases complete wound closure versus standard care in chronic ulcers, including diabetic foot and venous leg ulcers (odds ratios ≈ 2–8), and improves healing rates in pressure injuries (odds ratio ≈ 3.4), without increasing adverse events. In diabetic foot ulcers, PDGF-BB and EGF, together with PRP, consistently improve complete healing and reduce ulcer area. In burns, topical EGF and bFGF shorten healing time by ~3 days in superficial partial-thickness wounds and by >5 days in deeper burns, with generally improved scar outcomes.

Conclusions

PRP offers broad, autologous biologic activation, while recombinant growth factors deliver high-potency, targeted precision. Together, they represent complementary regenerative strategies that can shorten healing times and improve outcomes in chronic wounds. Standardized multicenter trials quantifying cytokine composition, cost-effectiveness, and long-term limb-salvage benefit are warranted to guide their integration into routine clinical practice.

Schlagwörter

Stichwörter der Autor:innen

basic fibroblast growth factor (bFGF)chronic ulcersdiabetic foot ulcersepidermal growth factor (EGF)platelet-derived growth factor (PDGF)platelet-rich plasmarecombinant growth factorsregenerative medicinevascular endothelial growth factor (VEGF)wound healing

Autor:innen und Institutionen

  • Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA.
  • Lake Erie College of Osteopathic Medicine, Elmira, NY 14901, USA.
  • School of Integrated Health Sciences, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA.
  • Department of Medical Education, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA.

ORCID-Profile: Abu-Bakr Ahmed, Joshua Khorsandi, Michael Lee, Adam Jaouhari, Aftab Merchant

Förderung

  • Kirk Kerkorian School of Medicine at the University of Nevada

Zitieren

APA

Ahmed, A. B., Thatcher, S., Khorsandi, J., Ahmed, Z., Lee, M., Jaouhari, A., Bond, B., & Merchant, A. (2025). Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions. Journal of Clinical Medicine, 14(23), 8583. https://doi.org/10.3390/jcm14238583

Vancouver

Ahmed AB, Thatcher S, Khorsandi J, Ahmed Z, Lee M, Jaouhari A, et al. Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions. Journal of Clinical Medicine. 2025;14(23):8583. doi:10.3390/jcm14238583

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Abu-Bakr and Thatcher, Spencer and Khorsandi, Joshua and Ahmed, Zahra and Lee, Michael and Jaouhari, Adam and Bond, Braydon and Merchant, Aftab},
  title = {Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {23},
  pages = {8583},
  doi = {10.3390/jcm14238583}
}
Kostenlos starten →